Akquamed Pharmaceuticals Private Limited
About Akquamed Pharmaceuticals Private Limited
Data last updated:
Akquamed Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2016PTC084468. Its GSTIN is 09AAPCA5068E1ZF (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anoop Kumar Agarwal and Anshul Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. – 9 & 10 Part Of 115/103 Shivaji Marg Bhagh Munnu, Lucknow, Uttar Pradesh, India – 226004.
As per the financials filed for FY 2024, the company reported a revenue of ₹65.5 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹3,848 (net margin -0.1%) and EBITDA of ₹7,032 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 37% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Akquamed Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. – 9 & 10 Part Of 115/103 Shivaji Marg Bhagh Munnu, Lucknow, Uttar Pradesh, India – 226004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Akquamed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Akquamed Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Akquamed Pharmaceuticals Private Limited, buy the company report.
Financials of Akquamed Pharmaceuticals Private Limited
FY 2025 filings availableAkquamed Pharmaceuticals Private Limited reported revenue of ₹65.5 Lakh (down 32% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 32% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 37%. EBITDA fell 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7,032 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3,848 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.1% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Akquamed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Akquamed Pharmaceuticals Private Limited
Akquamed Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anoop Kumar Agarwal | Director | 01 Jul 2021 | 5 Years 4 Months | Current |
| Anshul Agarwal | Director | 29 Jun 2016 | 10 Years 4 Months | Current |
Peer comparison
Akquamed Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zorif Pharmaceuticals Private Limited | ₹66.2 Lakh (FY 2024) | -9.0% | Delhi, India | |||
| Akquamed Pharmaceuticals Private Limitedthis company | ₹65.5 Lakh (FY 2024) | -₹3,848 | -0.1% | -32.0% | Lucknow, Uttar Pradesh, India | |
| Victro Pharmaceuticals Private Limited | ₹65.24 Lakh (FY 2025) | -30.0% | New Delhi, Delhi, India | |||
| Akon Pharmaceuticals Private Limited | ₹65.2 Lakh (FY 2024) | 196.0% | Surat, Gujarat, India | |||
| Zecon Pharmaceuticals Private Limited | ₹65.17 Lakh (FY 2024) | -77.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Akquamed Pharmaceuticals Private Limited, buy the company report.
Auditor
Akquamed Pharmaceuticals Private Limited is audited by VIMAL DIXIT & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIMAL DIXIT & ASSOCIATES | FY 2020 | 008805C |
Shareholding
The shareholding of Akquamed Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Akquamed Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Akquamed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Akquamed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Akquamed Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAPCA5068E1ZF | Uttar Pradesh | Active | 01 Sep 2017 |
To see the full GST registrations and return filing status of Akquamed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Akquamed Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Anoop Kumar Agarwal was appointed as Director on 01 Jul 2021.
Frequently asked questions
Akquamed Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 June 2016 (10+ years old) and is registered under CIN U51909UP2016PTC084468.
Akquamed Pharmaceuticals has 2 current directors:
- Anoop Kumar Agarwal - Director
- Anshul Agarwal - Director
The latest financial statements of Akquamed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Akquamed Pharmaceuticals is 09AAPCA5068E1ZF, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Akquamed Pharmaceuticals is U51909UP2016PTC084468. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akquamed Pharmaceuticals was incorporated on 29 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Akquamed Pharmaceuticals by revenue are Zorif Pharmaceuticals Private Limited, Victro Pharmaceuticals Private Limited, Akon Pharmaceuticals Private Limited, Zecon Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anoop Kumar Agarwal was appointed as Director on 01 Jul 2021. Kanishka ceased to be Director on 01 Jul 2021. Anshul Agarwal was appointed as Director on 29 Jun 2016.
The registered office of Akquamed Pharmaceuticals is at Plot No. – 9 & 10 Part Of 115103 Shivaji Marg Bhagh Munnu, Lucknow, Uttar Pradesh, India – 226004.
Akquamed Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Akquamed Pharmaceuticals is compliant as of 20 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
